Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Dalamaga

Showing results (21-30 of 261) with videos related to

Pageof 27
Sort By:
Metabolism Open|October 1, 2024
Diet patterns, gut microbiota and metabolic disorders: Perspectives and challengesMaria Dalamaga, Christina Tsigalou
Saudi Medical Journal|January 9, 2019
Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?Irene Karampela, Maria Dalamaga
Metabolism Open|December 17, 2021
DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASHMaria Dalamaga, Junli Liu
Expert Opinion on Pharmacotherapy|April 20, 2019
Can we better strategize our choice of pharmacotherapy for patients with co-morbid psoriasis and obesity?Maria Dalamaga, Evangelia Papadavid
Seminars in Cancer Biology|January 25, 2024
Special issue on "Excess body weight and cancer: Novel biologic insights and challenges"Maria Dalamaga, Nikolaos Spyrou
Hormone Molecular Biology and Clinical Investigation|June 10, 2015
Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignanciesMaria Dalamaga, Gerasimos S Christodoulatos
JAMA Dermatology|September 13, 2013
Remembering Louis Tribondeau (1872-1918)Maria Dalamaga, Antonis A Kousoulis
Metabolism Open|April 8, 2026
Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversiesIoannis G Lempesis, Maria Dalamaga
International Journal of Dermatology|June 6, 2014
Uncovering the life and work of Louis Tribondeau: a pioneer in dermatology and biochemistryMaria Dalamaga, Antonis A Kousoulis
World Journal of Clinical Oncology|May 16, 2014
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?Gerasimos Socrates Christodoulatos, Maria Dalamaga
Pageof 27

Showing results (21-30 of 261) with videos related to

Sort By:
Pageof 27
Metabolism Open|October 1, 2024
Diet patterns, gut microbiota and metabolic disorders: Perspectives and challengesMaria Dalamaga, Christina Tsigalou
Saudi Medical Journal|January 9, 2019
Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?Irene Karampela, Maria Dalamaga
Metabolism Open|December 17, 2021
DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASHMaria Dalamaga, Junli Liu
Expert Opinion on Pharmacotherapy|April 20, 2019
Can we better strategize our choice of pharmacotherapy for patients with co-morbid psoriasis and obesity?Maria Dalamaga, Evangelia Papadavid
Seminars in Cancer Biology|January 25, 2024
Special issue on "Excess body weight and cancer: Novel biologic insights and challenges"Maria Dalamaga, Nikolaos Spyrou
Hormone Molecular Biology and Clinical Investigation|June 10, 2015
Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignanciesMaria Dalamaga, Gerasimos S Christodoulatos
JAMA Dermatology|September 13, 2013
Remembering Louis Tribondeau (1872-1918)Maria Dalamaga, Antonis A Kousoulis
Metabolism Open|April 8, 2026
Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversiesIoannis G Lempesis, Maria Dalamaga
International Journal of Dermatology|June 6, 2014
Uncovering the life and work of Louis Tribondeau: a pioneer in dermatology and biochemistryMaria Dalamaga, Antonis A Kousoulis
World Journal of Clinical Oncology|May 16, 2014
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?Gerasimos Socrates Christodoulatos, Maria Dalamaga
Pageof 27